MedPath

Toulouse University Hospital

🇫🇷France
Ownership
Private
Employees
-
Market Cap
-
Website
https://www.chu-toulouse.fr

Cognitive Remediation Method by Rhythmic, Vocal and Embodied Musical Learning for Stabilized Schizophrenic Patients

Not Applicable
Completed
Conditions
Schizophrenia
Interventions
Other: cognitive remediation by musical training sessions
First Posted Date
2021-11-18
Last Posted Date
2023-03-31
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
20
Registration Number
NCT05124470
Locations
🇫🇷

CH Marchant, Toulouse, France

🇫🇷

CHU Toulouse, Toulouse, France

Monitoring of Progesterone Administered in Infertile Patients During a Cycle of Frozen Embryo Transfer.

Not Applicable
Recruiting
Conditions
IVF
Interventions
Other: Questionnaire
First Posted Date
2021-11-05
Last Posted Date
2022-11-15
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
200
Registration Number
NCT05109676
Locations
🇫🇷

CHU Toulouse, Toulouse, France

Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy

Not Applicable
Recruiting
Conditions
Neoplasm, Plasma Cell
Lymphoma
Interventions
Procedure: Comprehensive Geriatric Assessment
First Posted Date
2021-11-01
Last Posted Date
2023-12-20
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
100
Registration Number
NCT05101759
Locations
🇫🇷

University Hospital Toulouse, Toulouse, France

Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients

Phase 2
Conditions
Mastocytosis
Interventions
First Posted Date
2021-10-20
Last Posted Date
2021-10-20
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
30
Registration Number
NCT05084872
Locations
🇫🇷

Larrey Hospital - Toulouse University Hospital, Toulouse, France

Evaluation of Amoxicillin Diffusion in Breast Milk According to a Population Pharmacokinetic Approach (CONCEPTION-AMOX)

Phase 4
Completed
Conditions
Breast Feeding, Exclusive
Interventions
Biological: Blood and milk samples
First Posted Date
2021-09-21
Last Posted Date
2023-08-23
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
25
Registration Number
NCT05051787
Locations
🇫🇷

APHP Hôpital Necker, Lactarium Régional d'Ile de France, Paris, France

🇫🇷

CHU Toulouse, Toulouse, France

Patient Satisfaction With the Management of a Stopped Pregnancy in the First Trimester

Not Applicable
Completed
Conditions
Pregnancy Loss, Early
Interventions
Drug: Medical treatment with Mifégyne® and MisoOne®
Procedure: Endo-uterine aspiration
First Posted Date
2021-09-20
Last Posted Date
2022-03-14
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
52
Registration Number
NCT05049980
Locations
🇫🇷

Mickael ALLOUCHE, Toulouse, France

Impact of Adjuvant Hormone Therapy on Bone and Cardiovascular Risk

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Other: Questionnaire
First Posted Date
2021-09-17
Last Posted Date
2022-03-02
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
102
Registration Number
NCT05049031
Locations
🇫🇷

CHU Toulouse, Toulouse, France

Distribution of Knee Isokinetic Angle-specific Moments and Ratios

Not Applicable
Completed
Conditions
Musculoskeletal Diseases
Interventions
Other: Evaluation of the strength of knee flexors and extensors
First Posted Date
2021-09-13
Last Posted Date
2022-07-13
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
70
Registration Number
NCT05041400
Locations
🇫🇷

Marc Antoine DEMARET, Toulouse, France

Biobank for Inflammatory Chronic Diseases and Osteoporosis

Recruiting
Conditions
Spondyloarthritis
Osteoporosis
Rheumatoid Arthritis
Psoriatic Arthritis
Interventions
Biological: Blood sampling
First Posted Date
2021-09-09
Last Posted Date
2024-12-11
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
2000
Registration Number
NCT05039216
Locations
🇫🇷

Purpan University Hospital, Toulouse, France

Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial

Phase 3
Recruiting
Conditions
Prader-Willi Syndrome
Interventions
Drug: Follow-up study of the treated cohort
Other: Follow-up study of the untreated cohort
First Posted Date
2021-09-02
Last Posted Date
2024-04-30
Lead Sponsor
University Hospital, Toulouse
Target Recruit Count
80
Registration Number
NCT05032326
Locations
🇫🇷

Hôpital Femme Mère Enfant, Bron, France

🇫🇷

CHU Dijon Hôpital des Enfants, Dijon, France

🇫🇷

CHU de Grenoble, Grenoble, France

and more 9 locations
© Copyright 2025. All Rights Reserved by MedPath